Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05012462 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the CM-1500 During Apheresis Blood Donation
A NA study of Fluid Loss, sponsored by Zynex Monitoring Solutions.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
- 1
- Study location
NCT05012462 is a NA study of Fluid Loss that has completed, run by Zynex Monitoring Solutions. The registered enrollment target is 77 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05012462, a NA study of Fluid Loss, has completed, sponsored by Zynex Monitoring Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a prospective, single-arm, non-randomized, non-blinded, non-controlled, non-significant risk, single center study enrolling up to 200 healthy adult subjects consented to undergo an apheresis donation procedure. Subjects will be connected to the Zynex Cardiac Monitor, Model 1500 (CM-1500) to characterize changes in the relative index during an apheresis donation procedure.
Conditions Studied
Interventions
- DEVICE CM-1500
- DEVICE CM-1600
Study Locations (1)
Colorado
- Vitalant Blood Donation - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2021-09-20 |
| Est. Completion | 2022-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05012462
The ClinicalTrials.gov registry entry for NCT05012462 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zynex Monitoring Solutions, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fluid Loss appearing as the primary indexed condition, and to 2 interventions - of which CM-1500 is the first listed.
NCT05012462 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT05012462 about?
NCT05012462 is a clinical study titled "Clinical Evaluation of the CM-1500 During Apheresis Blood Donation". The study is a prospective, single-arm, non-randomized, non-blinded, non-controlled, non-significant risk, single center study enrolling up to 200 healthy adult subjects consented to undergo an apheresis donation procedure. Subjects will be connected to the Zynex Cardiac Monitor, Model 1500 (CM-1500...
What is the current status of trial NCT05012462?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2021-09-20. Estimated completion is 2022-12-20.
What conditions does trial NCT05012462 study?
This clinical trial studies the following conditions: Fluid Loss.
What interventions are being tested in trial NCT05012462?
The interventions under investigation include: CM-1500 (DEVICE), CM-1600 (DEVICE).
Who is sponsoring clinical trial NCT05012462?
This trial is sponsored by Zynex Monitoring Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05012462 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.